SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-007527
Filing Date
2024-10-31
Accepted
2024-10-31 17:00:08
Documents
13
Period of Report
2024-10-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT xenetic_8k.htm   iXBRL 8-K 28935
  Complete submission text file 0001683168-24-007527.txt   200079

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE xbio-20241029.xsd EX-101.SCH 3021
3 XBRL LABEL FILE xbio-20241029_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE xbio-20241029_pre.xml EX-101.PRE 22363
15 EXTRACTED XBRL INSTANCE DOCUMENT xenetic_8k_htm.xml XML 3572
Mailing Address 945 CONCORD ST. FRAMINGHAM MA 01701
Business Address 945 CONCORD ST. FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Filer) CIK: 0001534525 (see all company filings)

IRS No.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37937 | Film No.: 241415965
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)